English | Español
Gene Johnson | Apr 9, 2017

American Cancer Society releases tips to lower risk of colon cancer
Robert Hadley | Apr 7, 2017

FDA accelerates review for drug that treats blood-clotting disease
Robert Hadley | Apr 7, 2017

Early tests show Opdivo triples life expectancy in lung-cancer patients
Erianne Leatherman | Apr 7, 2017

Repatha shows no memory effects while lowering LDL levels, study finds
Robert Hadley | Apr 7, 2017

Generic arthritis medicine shown effective in clinical trial

Robert Hadley | Apr 6, 2017

FDA clears ovarian cancer drug for broad uses
Robert Hadley | Apr 6, 2017

New ALS test may speed clinical trials
Kyle Perrotti | Apr 6, 2017

Parker Institute, Cancer Research Institute join forces for project

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’